Quent Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-189
| Closed | -$13.4K | – | 400 |
|
|
2025
Q1 | $13.4K | Buy |
189
+33
| +21% | +$2.33K | ﹤0.01% | 856 |
|
|
2024
Q4 | $10.3K | Sell |
156
-100
| -39% | -$6.57K | ﹤0.01% | 930 |
|
|
2024
Q3 | $18K | Sell |
256
-135
| -35% | -$9.49K | ﹤0.01% | 905 |
|
|
2024
Q2 | $32.2K | Buy |
391
+145
| +59% | +$11.9K | ﹤0.01% | 743 |
|
|
2024
Q1 | $21.5K | Sell |
246
-112
| -31% | -$9.78K | ﹤0.01% | 863 |
|
|
2023
Q4 | $34.5K | Buy |
358
+23
| +7% | +$2.22K | ﹤0.01% | 706 |
|
|
2023
Q3 | $29.6K | Sell |
335
-1,223
| -78% | -$108K | ﹤0.01% | 707 |
|
|
2023
Q2 | $135K | Buy |
1,558
+23
| +1% | +$1.99K | 0.02% | 358 |
|
|
2023
Q1 | $147K | Buy |
1,535
+1,374
| +853% | +$131K | 0.03% | 337 |
|
|
2022
Q4 | $16.7K | Hold |
161
| – | – | ﹤0.01% | 804 |
|
|
2022
Q3 | $14K | Buy |
161
+12
| +8% | +$1.04K | ﹤0.01% | 799 |
|
|
2022
Q2 | $12K | Hold |
149
| – | – | ﹤0.01% | 793 |
|
|
2022
Q1 | $11K | Buy |
149
+30
| +25% | +$2.22K | ﹤0.01% | 887 |
|
|
2021
Q4 | $11K | Buy |
+119
| New | +$11K | ﹤0.01% | 803 |
|